概述
-
货号
DVV03805
-
描述
Lesofavumab is a Recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing lesofavumab (RG 6024), a monoclonal antibody, for the treatment of influenza B infections.
-
表达系统
Mammalian Cells -
种属反应性
Influenza B virus -
宿主
Human -
同种型
IgG1, kappa -
克隆类型
Monoclonal -
靶标
HA/Hemagglutinin -
浓度
1 mg/ml -
内毒素水平
Please contact with the lab for this information. -
纯度
>95% as determined by SDS-PAGE. -
纯化方式
Protein A/G purified from cell culture supernatant. -
Accession号
P03461 -
克隆号
Lesofavumab
-
应用
Research Grade Biosimilar -
状态
Liquid -
保存溶液
0.01M PBS, pH 7.4. -
稳定性和存储
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. -
别名
RG6024, RG 6024, MHAB5553A, RG70026, RO7045557, CAS: 1807960-57-1
图片
参考文献
评价
